loader

nasdaq:vrtx

LATEST ARTICLES
pharmaceutical investing

Vertex Announces Northern Ireland Offer Accepted for Cystic Fibrosis Treatments

NASDAQ:AZRX

AzurRx BioPharma Dips on Phase 2 Trial Results for MS1819

NASDAQ:VRTX

Vertex’s Cystic Fibrosis Drug Receives Nod from EU

CRISPR Therapeutics and Vertex Announce FDA Has Lifted a Clinical Hold

Health Canada Approves PrSYMDEKO (tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of Cystic Fibrosis

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES